04/02/2024 3:15 PM | Fisher Andrew (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024 7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024 6:45 PM | Gupta Rishi (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024 8:40 PM | Fisher Andrew (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/04/2024 7:15 PM | ORBIMED ADVISORS LLC (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/29/2024 8:00 AM | Verona Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 5:08 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 5:09 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:11 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:11 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 5:05 AM | Austwick Michael (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/02/2024 5:07 AM | Austwick Michael (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 3:15 PM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 4:09 PM | Edwards Martin (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 3:15 PM | EBSWORTH DAVID R (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:08 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:09 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:09 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:11 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:25 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:16 PM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 5:24 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 3:06 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 3:06 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:05 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 3:05 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:15 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:17 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:17 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:19 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:31 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:27 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:29 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:30 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 3:12 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
War Over Taiwan? Protect Your Wealth NOW (Ad) With tensions rapidly escalating, Taiwan could provide the spark at any moment.
Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> |
08/03/2023 7:34 AM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 5:11 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 5:06 PM | Gupta Rishi (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 5:07 PM | ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 5:18 PM | ORBIMED ADVISORS LLC (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023 7:47 AM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023 5:13 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2023 6:46 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:48 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:49 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:49 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 3:38 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2023 4:21 PM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2023 3:24 PM | Deschamps Lisa (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2023 3:16 PM | Verona Pharma (Subject)
| Form SC 13G/A | |
04/25/2023 3:16 PM | Access Industries Holdings LLC (Filed by) Access Industries Holdings LLC (Filed by) Verona Pharma (Subject)
| Form SC 13G/A | |